Agency Report to JCAR-Page 2
4. Summary of proposed rules:
The proposed revisions to the rules will: adopt the federal schedule of controlled substances; clarify
when a controlled substance license is required; modify the requirements for opioids and other
controlled substances training; modify the licensure requirements for prescribers who provide
maintenance or detoxification treatment in the course of their professional practice or who are
registered with the DEA to provide such treatment; clarify when a licensee may prescribe, dispense,
and administer a controlled substance to a drug dependent individual; clarify “significant” loss;
clarify when an inventory of controlled substances is required; modify record retention to two years
for most records and 5 years for an original prescription; provide the requirements for electronic
transmission of prescriptions; provide the process for a waiver from the mandate to electronically
transmit a prescription; and modify reporting to the electronic system for monitoring.
5. List names of newspapers in which the notice of public hearing was published and
publication dates:
Marquette Mining Journal – August 15, 2021; Flint Journal – August 15, 2021; Grand Rapids Press –
August 19, 2021
6. Date of publication of rules and notice of public hearing in Michigan Register:
9/1/2021
7. Date, time, and location of public hearing:
9/9/2021 01:00 PM at Location: G. Mennen Williams Building Auditorium , 525 W. Ottawa Street,
Lansing, Michigan
8. Provide the link the agency used to post the regulatory impact statement and cost-benefit
analysis on its website:
9. List of the name and title of agency representative(s) attending public hearing:
Kerry Przybylo, Manager; Andria Ditschman, Senior Policy Analyst; and Stephanie Wysack, Board
Support.
10. Persons submitting comments of support:
The following persons submitted comments in support:
Adam Carlson, Vice President, Advocacy, Michigan Health & Hospital Association (MHA)
Deeb Eid, Advisor, Pharmacy Regulatory Affairs, CVS Health
Timothy Gammons, President, Michigan Society of Addiction Medicine (MISAM)
Julie Novak, Chief Executive Officer, Michigan State Medical Society (MSMS)
11. Persons submitting comments of opposition:
MCL 24.242 and 24.245